SCA
IRWD icon

Secor Capital Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

Secor Capital Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-39,764
Closed -$499K – 574
2017
Q4 		$499K Buy
+39,764
New +$519K 0.02% 366
2014
Q4 		– Sell
-14,101
Closed -$153K – 418
2014
Q3 		$153K Sell
14,101
-17,040
-55% -$195K 0.09% 295
2014
Q2 		$400K Sell
31,141
-6,998
-18% -$76.1K 0.21% 174
2014
Q1 		$394K Buy
+38,139
New +$429K 0.19% 196

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Secor Capital Advisors's IRWD Position: Q1 2018 in Review

Secor Capital Advisors sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2018, closing a stake of 39,764 shares — an estimated $499K sold.

Secor Capital Advisors first reported a position in IRWD in Q1 2014 and held it in 4 quarters. The position peaked at $499K in Q4 2017. 149 funds tracked by Wall St. Rank hold IRWD as of Q1 2018.

  • Secor Capital Advisors reported no remaining Ironwood Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • Secor Capital Advisors sold 39,764 Ironwood Pharmaceuticals shares in Q1 2018, an estimated $499K.
  • Secor Capital Advisors first reported a position in Ironwood Pharmaceuticals in Q1 2014 and held it in 4 quarters.
  • Secor Capital Advisors's Ironwood Pharmaceuticals position peaked at $499K in Q4 2017.
  • 149 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2018.

Based on Secor Capital Advisors's 13F filing for Q1 2018, filed 15 May 2018.